Literature DB >> 8605233

Purification and characterization of N-acetylmuramyl-L-alanine amidase from human plasma using monoclonal antibodies.

M A Hoijer1, M J Melief, W Keck, M P Hazenberg.   

Abstract

N-Acetylmuramyl-L-alanine amidase (EC 3.5.1.28) cleaves the amide bond between N-acetyl muramic acid and L-alanine in the peptide side chain of different peptidoglycan products. The enzyme was purified from human plasma using a three-step column chromatography procedure. Monoclonal antibodies were produced against the purified human enzyme. By coupling of a high affinity monoclonal antibody to sepharose beads an immunoadsorbent column was prepared. Using this second purification method it was possible to purify large amounts of the amidase from human plasma in a single step. SDS-PAGE showed one single band of 70 kDa and two-dimensional electrophoresis showed the presence of multiple isomeric forms of the protein with pI between 6.5 and 7.9. Two different methods were used for determination of substrate specificity, a HPLC method separating peptidoglycan monomers from the reaction products after incubation with amidase and a colorimetric method when high molecular weight peptidoglycan was used as a substrate for amidase. It is shown that the disaccharide tetra peptide, disaccharide penta peptide and the anhydro disaccharide tetrapeptide are good substrates for the amidase and that muramyl dipeptide and disaccharide dipeptide are not a substrate for the amidase. Using one of the monoclonal antibodies against the amidase it was shown in FACScan analysis that N-acetylmuramyl-L-alanine amidase is present in granulocytes but not in monocytes from unstimulated peripheral blood of a healthy donor. The presence of N-acetylmuramyl-L-alanine amidase in granulocytes is a novel finding and perhaps important for the inactivation of biologically active peptidoglycan products still present after hydrolysis by lysozyme.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605233     DOI: 10.1016/0304-4165(95)00136-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Phagocytes containing a disease-promoting Toll-like receptor/Nod ligand are present in the brain during demyelinating disease in primates.

Authors:  Lizette Visser; Marie-José Melief; Debby van Riel; Marjan van Meurs; Ella A Sick; Seiichi Inamura; Jeffrey J Bajramovic; Sandra Amor; Rogier Q Hintzen; Leonie A Boven; Bert A 't Hart; Jon D Laman
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

Review 2.  How innate immunity proteins kill bacteria and why they are not prone to resistance.

Authors:  Roman Dziarski; Dipika Gupta
Journal:  Curr Genet       Date:  2017-08-24       Impact factor: 3.886

3.  Bacterial cell wall-induced arthritis: chemical composition and tissue distribution of four Lactobacillus strains.

Authors:  E Simelyte; M Rimpiläinen; L Lehtonen; X Zhang; P Toivanen
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

4.  Peptidoglycan recognition protein 2 (N-acetylmuramoyl-L-Ala amidase) is induced in keratinocytes by bacteria through the p38 kinase pathway.

Authors:  Haitao Wang; Dipika Gupta; Xinna Li; Roman Dziarski
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

Review 5.  Beyond Metabolism: Role of the Immune System in Hepatic Toxicity.

Authors:  Kenneth L Hastings; Martin D Green; Bin Gao; Patricia E Ganey; Robert A Roth; Gary R Burleson
Journal:  Int J Toxicol       Date:  2020 Mar/Apr       Impact factor: 2.032

6.  Peptidoglycan recognition proteins kill bacteria by inducing oxidative, thiol, and metal stress.

Authors:  Des Raj Kashyap; Annemarie Rompca; Ahmed Gaballa; John D Helmann; Jefferson Chan; Christopher J Chang; Iztok Hozo; Dipika Gupta; Roman Dziarski
Journal:  PLoS Pathog       Date:  2014-07-17       Impact factor: 6.823

Review 7.  Hepatocytes: a key cell type for innate immunity.

Authors:  Zhou Zhou; Ming-Jiang Xu; Bin Gao
Journal:  Cell Mol Immunol       Date:  2015-12-21       Impact factor: 11.530

8.  Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus: quantitative measurements and biological reactivities.

Authors:  P van Langevelde; J T van Dissel; E Ravensbergen; B J Appelmelk; I A Schrijver; P H Groeneveld
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.